BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32458006)

  • 21. Radiation Dosimetry and Biodistribution of
    Piron S; De Man K; Van Laeken N; D'Asseler Y; Bacher K; Kersemans K; Ost P; Decaestecker K; Deseyne P; Fonteyne V; Lumen N; Achten E; Brans B; De Vos F
    J Nucl Med; 2019 Dec; 60(12):1736-1742. PubMed ID: 31028165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer.
    Cho SY; Gage KL; Mease RC; Senthamizhchelvan S; Holt DP; Jeffrey-Kwanisai A; Endres CJ; Dannals RF; Sgouros G; Lodge M; Eisenberger MA; Rodriguez R; Carducci MA; Rojas C; Slusher BS; Kozikowski AP; Pomper MG
    J Nucl Med; 2012 Dec; 53(12):1883-91. PubMed ID: 23203246
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biodistribution and radiation dosimetry in cancer patients of the ascorbic acid analogue 6-Deoxy-6-[
    Long Y; Yi C; Wu R; Zhang Y; Zhang B; Shi X; Zhang X; Zha Z
    Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):3072-3083. PubMed ID: 37191679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions.
    Afshar-Oromieh A; Hetzheim H; Kratochwil C; Benesova M; Eder M; Neels OC; Eisenhut M; Kübler W; Holland-Letz T; Giesel FL; Mier W; Kopka K; Haberkorn U
    J Nucl Med; 2015 Nov; 56(11):1697-705. PubMed ID: 26294298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [
    Green MA; Hutchins GD; Bahler CD; Tann M; Mathias CJ; Territo W; Sims J; Polson H; Alexoff D; Eckelman WC; Kung HF; Fletcher JW
    Mol Imaging Biol; 2020 Jun; 22(3):752-763. PubMed ID: 31429050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biodistribution and radiation dosimetry of D-isomer of 4-borono-2-[
    Yang Q; Zhu W; Ren C; Ji H; Wang D; Liu Y; Li F; Du Y; Liu Y; Huo L
    Nucl Med Biol; 2021; 94-95():32-37. PubMed ID: 33486437
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    O'Doherty J; Jauregui-Osoro M; Brothwood T; Szyszko T; Marsden PK; O'Doherty MJ; Cook GJR; Blower PJ; Lewington V
    J Nucl Med; 2017 Oct; 58(10):1666-1671. PubMed ID: 28385795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biodistribution and radiation dosimetry of 18F-CP-18, a potential apoptosis imaging agent, as determined from PET/CT scans in healthy volunteers.
    Doss M; Kolb HC; Walsh JC; Mocharla V; Fan H; Chaudhary A; Zhu Z; Alpaugh RK; Lango MN; Yu JQ
    J Nucl Med; 2013 Dec; 54(12):2087-92. PubMed ID: 24136934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [44Sc]Sc-PSMA-617 Biodistribution and Dosimetry in Patients With Metastatic Castration-Resistant Prostate Carcinoma.
    Khawar A; Eppard E; Sinnes JP; Roesch F; Ahmadzadehfar H; Kürpig S; Meisenheimer M; Gaertner FC; Essler M; Bundschuh RA
    Clin Nucl Med; 2018 May; 43(5):323-330. PubMed ID: 29485430
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First-in-human study of PSMA-targeting agent, [
    Zhao R; Ke M; Lv J; Liu S; Liu Y; Zhang J; Xu L; Gu D; Li M; Cai C; Liu Y; Zeng G; Alexoff D; Ploessl K; Zhu L; Kung HF; Wang X
    Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1753-1762. PubMed ID: 38212531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase I study to assess safety, biodistribution and radiation dosimetry for
    Merkx RIJ; Lobeek D; Konijnenberg M; Jiménez-Franco LD; Kluge A; Oosterwijk E; Mulders PFA; Rijpkema M
    Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3277-3285. PubMed ID: 33651116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biodistribution and Dosimetry of
    Pandit-Taskar N; Zanzonico P; Staton KD; Carrasquillo JA; Reidy-Lagunes D; Lyashchenko S; Burnazi E; Zhang H; Lewis JS; Blasberg R; Larson SM; Weber WA; Modak S
    J Nucl Med; 2018 Jan; 59(1):147-153. PubMed ID: 28705916
    [No Abstract]   [Full Text] [Related]  

  • 33. A Prospective Comparison of
    Anttinen M; Ettala O; Malaspina S; Jambor I; Sandell M; Kajander S; Rinta-Kiikka I; Schildt J; Saukko E; Rautio P; Timonen KL; Matikainen T; Noponen T; Saunavaara J; Löyttyniemi E; Taimen P; Kemppainen J; Dean PB; Blanco Sequeiros R; Aronen HJ; Seppänen M; Boström PJ
    Eur Urol Oncol; 2021 Aug; 4(4):635-644. PubMed ID: 32675047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biokinetics and dosimetry of
    Hvittfeldt E; Bjöersdorff M; Brolin G; Minarik D; Svegborn SL; Oddstig J; Trägårdh E
    Clin Physiol Funct Imaging; 2022 Nov; 42(6):443-452. PubMed ID: 36039853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical translation of
    Dubash SR; Keat N; Kozlowski K; Barnes C; Allott L; Brickute D; Hill S; Huiban M; Barwick TD; Kenny L; Aboagye EO
    Eur J Nucl Med Mol Imaging; 2020 Oct; 47(11):2549-2561. PubMed ID: 32123971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 68Ga-labeled PSMA-11 (68Ga-isoPROtrace-11) synthesized with ready to use kit: normal biodistribution and uptake characteristics of tumour lesions.
    Kurash MM; Gill R; Khairulin M; Harbosh H; Keidar Z
    Sci Rep; 2020 Feb; 10(1):3109. PubMed ID: 32080309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Initial evaluation of PET/CT with
    Saga T; Nakamoto Y; Ishimori T; Inoue T; Shimizu Y; Kimura H; Akamatsu S; Goto T; Watanabe H; Kitaguchi K; Watanabe M; Ono M; Saji H; Ogawa O; Togashi K
    Cancer Sci; 2019 Feb; 110(2):742-750. PubMed ID: 30549183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer.
    Afshar-Oromieh A; Zechmann CM; Malcher A; Eder M; Eisenhut M; Linhart HG; Holland-Letz T; Hadaschik BA; Giesel FL; Debus J; Haberkorn U
    Eur J Nucl Med Mol Imaging; 2014 Jan; 41(1):11-20. PubMed ID: 24072344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiation Dosimetry and Biodistribution of
    Meyer C; Dahlbom M; Lindner T; Vauclin S; Mona C; Slavik R; Czernin J; Haberkorn U; Calais J
    J Nucl Med; 2020 Aug; 61(8):1171-1177. PubMed ID: 31836685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pilot-phase PET/CT study targeting integrin α
    Nakamoto R; Ferri V; Duan H; Hatami N; Goel M; Rosenberg J; Kimura R; Wardak M; Haywood T; Kellow R; Shen B; Park W; Iagaru A; Gambhir SS
    Eur J Nucl Med Mol Imaging; 2022 Dec; 50(1):184-193. PubMed ID: 34729628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.